Abstract:We have recently reported that apoptosis of T cells induced by squamous cell carcinoma of the head and neck (SCCHN) is partly Fas dependent. This tumor-induced T-cell death is mediated by the activities of caspase-8 and caspase-3 and is partially inhibited by antibodies to either Fas or Fas ligand. We report here that in contrast to apoptosis induced by agonistic anti-Fas antibody (Ab), the tumor-induced apoptotic cascade in Jurkat cells is significantly amplified by a mitochondrial loop. The involvement of mitochondria in tumor-induced apoptosis of T cells was demonstrated by changes in mitochondrial permeability transition as assessed by 3,3'-dihexiloxadicarbocyanine staining, by cleavage of cytosolic BID and its translocation to the mitochondria, by release of cytochrome c to the cytosol, and by the presence of active subunits of caspase-9 in Jurkat T cells cocultured with tumor cells. To further elucidate the significance of mitochondria in tumor-induced T-cell death, we investigated the effects of various inhibitors of the mitochondrial pathway. Specific antioxidants, as well as two inhibitors of mitochondria permeability transition, bongkrekic acid and cyclosporin A, significantly blocked the DNA degradation induced in Jurkat T cells by SCCHN cells. However, these inhibitors had no effect on cells triggered by anti-Fas Ab. Furthermore, a cell-permeable inhibitor of caspase-9, Ac-LEHD.CHO, which did not inhibit T-cell apoptosis induced by anti-Fas Ab, markedly inhibited apoptosis induced by etoposide or by coculture of Jurkat with SCCHN cells. These findings demonstrate that apoptotic cascades induced in Jurkat T lymphocytes by anti-Fas Ab or tumor cells are differentially susceptible to a panel of inhibitors of mitochondrial apoptotic events. It appears that besides the Fas-mediated pathway, additional mitochondria-dependent cascades are involved in apoptosis of tumor-associated lymphocytes. Inhibition of mitochondria-dependent cascades of caspase activation should be considered to enhance the success of immunotherapy or vaccination protocols in cancer.

TUMOUR NECROSIS FACTOR-INDUCED NECROSIS VERSUS ANTI-Fas-INDUCED APOPTOSIS IN L929 CELLS

Influence of inhibitor of signal transduction on the cell apoptosis induced by TNF β

Considering Fas ligand as a target for therapy.

The Fas Ligand As a Cell Death Factor and Signal Transducer

Activation‐dependent FasL Expression in T Lymphocytes and Natural Killer Cells

The Adaptor Protein Nck Interacts with Fas Ligand: Guiding the Death Factor to the Cytotoxic Immunological Synapse

Study on the Signal Transduction in Apoptosis of L929 Cell Induced by IFNγ-LTα and LTα

Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF

TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members

Tumor-induced Apoptosis of T Cells: Amplification by a Mitochondrial Cascade.

Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule

Loss of FADD and Caspases Affects the Response of T-Cell Leukemia Jurkat Cells to Anti-Cancer Drugs

Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

Necroptosis Occurs in Osteoblasts During Tumor Necrosis Factor-Α Stimulation and Caspase-8 Inhibition

Fas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic Mutations

Apoptosis-Resistant Mitochondria in T Cells Selected for Resistance to Fas Signaling

NF-κB Signaling and Cell-Fate Decision Induced by a Fast-Dissociating Tumor Necrosis Factor Mutant.

Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF‐R1 activation by endogenous membrane‐anchored TNF

Stabilized β-Catenin Potentiates Fas-Mediated T Cell Apoptosis

Stabilized beta-catenin potentiates Fas-mediated T cell apoptosis.